Literature DB >> 3949113

Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study.

D Valla, M G Le, T Poynard, N Zucman, B Rueff, J P Benhamou.   

Abstract

In a case-control study, we evaluated the relative risk of hepatic vein thrombosis among recent oral contraceptive users as compared with nonusers. Thirty-three cases of hepatic vein thrombosis affecting women aged 15-45 yr were collected between 1970 and 1983, and individually matched to 3 or 4 controls interviewed in 1982-1984. There were 18 recent oral contraceptive users among the 33 cases, and 44 recent oral contraceptive users among the 128 case-matched controls. The relative risk of hepatic vein thrombosis was 2.37 (95% confidence interval: 1.05-5.34, p less than 0.02). The relative risk of hepatic vein thrombosis is close to that of stroke, myocardial infarction, and venous thromboembolism among oral contraceptive users as compared with nonusers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949113     DOI: 10.1016/0016-5085(86)90855-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

Review 1.  Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.

Authors:  Valerio De Stefano; Ida Martinelli
Journal:  Intern Emerg Med       Date:  2010-06-08       Impact factor: 3.397

Review 2.  Budd-Chiari syndrome: etiology, pathogenesis and diagnosis.

Authors:  Musa Aydinli; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

3.  Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome.

Authors:  M D Uhl; D B Roth; C A Riely
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

4.  Factor V Leiden related Budd-Chiari syndrome.

Authors:  P Deltenre; M H Denninger; S Hillaire; M C Guillin; N Casadevall; J Brière; S Erlinger; D C Valla
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Imaging and interventions in Budd-Chiari syndrome.

Authors:  Amar Mukund; Shivanand Gamanagatti
Journal:  World J Radiol       Date:  2011-07-28

Review 6.  Pregnancy and vascular liver disease.

Authors:  Julien Bissonnette; François Durand; Emmanuelle de Raucourt; Pierre-François Ceccaldi; Aurélie Plessier; Dominique Valla; Pierre-Emmanuel Rautou
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

7.  Acute Budd-Chiari syndrome with hepatic failure and obstruction of the inferior vena cava as presenting manifestations of hereditary protein C deficiency.

Authors:  M Bourlière; Y P Le Treut; D Arnoux; P Castellani; L Bordigoni; A Maillot; M Antoni; D Botta; B Pol; A P Gauthier
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

8.  Liver transplantation for the Budd-Chiari syndrome.

Authors:  G Halff; S Todo; A G Tzakis; R D Gordon; T E Starzl
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

9.  Risk factors of thrombosis in abdominal veins.

Authors:  Amit-Kumar Dutta; Ashok Chacko; Biju George; Joseph Anjilivelil Joseph; Sukesh Chandran Nair; Vikram Mathews
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

10.  Suprahepatic Budd-Chiari syndrome treated with thrombectomy and cavoplasty.

Authors:  John Rhee; Anthony J Demetris; Kareem Abu Elmagd; Mordechai Rabinovitz
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.